1251 - 1300 of 8818 Results
Title
Year
-
RESTRICTEDTitle: DYT‐TUBB4A (DYT4 Dystonia): Clinical Anthology of 11 Cases and Systematized ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 5Start Page: 659End Page: 675Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13452Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13452Citation Count: 7
-
RESTRICTEDTitle: Age Cutoff for Early‐Onset Parkinson's Disease: Recommendations from the International Parkinson and Movement Disorder Society Task Force on Early Onset Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 869End Page: 878Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13523Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13523Citation Count: 33
-
RESTRICTEDTitle: Childhood‐Onset Choreo‐Dystonia Due to a Recurrent Novel Homozygous Nonsense HPCA Variant: Case Series and Literature ReviewJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 10Issue #: 1Start Page: 101End Page: 108Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mdc3.13529Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13529Citation Count: 2
-
RESTRICTEDTitle: Urate: a novel biomarker of Parkinson’s disease risk, diagnosis and prognosisJournal Name: Biomarkers in MedicinePublisher: Informa UK LimitedVol: 4Issue #: 5Start Page: 701End Page: 712Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/bmm.10.94Best OA location URL: https://europepmc.org/articles/pmc3049925?pdf=renderCitation Count: 119
-
RESTRICTEDTitle: Activation of the E3 ubiquitin ligase ParkinJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 43Issue #: 2Start Page: 269End Page: 274Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20140321Best OA location URL: https://europepmc.org/articles/pmc4859148?pdf=renderCitation Count: 45
-
RESTRICTEDTitle: LRRK2 GTPase dysfunction in the pathogenesis of Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 40Issue #: 5Start Page: 1074End Page: 1079Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1042/bst20120093Best OA location URL: https://europepmc.org/articles/pmc3701022?pdf=renderCitation Count: 20
-
RESTRICTEDTitle: The LRRK2–macroautophagy axis and its relevance to Parkinson's diseaseJournal Name: Biochemical Society TransactionsPublisher: Portland Press Ltd.Vol: 45Issue #: 1Start Page: 155End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bst20160265Best OA location URL: https://portlandpress.com/biochemsoctrans/article-pdf/45/1/155/432837/bst-2016-0265.pdfCitation Count: 61
-
RESTRICTEDTitle: Ubiquitin and Parkinson's disease through the looking glass of geneticsJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 474Issue #: 9Start Page: 1439End Page: 1451Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1042/bcj20160498Best OA location URL: https://portlandpress.com/biochemj/article-pdf/474/9/1439/689414/bcj-2016-0498c.pdfCitation Count: 54
-
RESTRICTEDTitle: Current Challenges Towards the Development of a Blood Test for Parkinson’s DiseaseJournal Name: DiagnosticsPublisher: MDPI AGVol: 4Issue #: 4Start Page: 153End Page: 164Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/diagnostics4040153Best OA location URL: https://www.mdpi.com/2075-4418/4/4/153/pdf?version=1413988424Citation Count: 9
-
RESTRICTEDTitle: Vesicular degradation pathways in neurons: at the crossroads of autophagy and endo-lysosomal degradationJournal Name: Current Opinion in NeurobiologyPublisher: Elsevier BVVol: 57Issue #:Start Page: 94End Page: 101Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.conb.2019.01.005Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629518Citation Count: 21
-
RESTRICTEDTitle: The Therapeutic Potential of Metformin in Neurodegenerative DiseasesJournal Name: Frontiers in EndocrinologyPublisher: Frontiers Media SAVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fendo.2018.00400Best OA location URL: https://www.frontiersin.org/articles/10.3389/fendo.2018.00400/pdfCitation Count: 209
-
RESTRICTEDTitle: Proceedings of the Fourth Annual Deep Brain Stimulation Think Tank: A Review of Emerging Issues and TechnologiesJournal Name: Frontiers in Integrative NeurosciencePublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnint.2016.00038Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnint.2016.00038/pdfCitation Count: 50
-
RESTRICTEDTitle: Role of Peripheral Immune Cells for Development and Recovery of Chronic PainJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.641588Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2021.641588/pdfCitation Count: 29
-
RESTRICTEDTitle: Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T CellsJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00303Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00303/pdfCitation Count: 121
-
RESTRICTEDTitle: Structural biology of the LRRK2 GTPase and kinase domains: implications for regulationJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00032Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00032/pdfCitation Count: 71
-
RESTRICTEDTitle: Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disordersJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2014.00048Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2014.00048/pdfCitation Count: 69
-
RESTRICTEDTitle: Crosstalk between Lysosomes and Mitochondria in Parkinson's DiseaseJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 5Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2017.00110Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2017.00110/pdfCitation Count: 77
-
RESTRICTEDTitle: Current Evidence for a Bidirectional Loop Between the Lysosome and Alpha-Synuclein ProteoformsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.598446Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.598446/pdfCitation Count: 18
- In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and Cons2020RESTRICTEDTitle: In Search of Effective Treatments Targeting α-Synuclein Toxicity in Synucleinopathies: Pros and ConsJournal Name: Frontiers in Cell and Developmental BiologyPublisher: Frontiers Media SAVol: 8Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fcell.2020.559791Best OA location URL: https://www.frontiersin.org/articles/10.3389/fcell.2020.559791/pdfCitation Count: 15
-
RESTRICTEDTitle: Neurodegeneration: Keeping ATF4 on a Tight LeashJournal Name: Frontiers in Cellular NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fncel.2017.00410Best OA location URL: https://www.frontiersin.org/articles/10.3389/fncel.2017.00410/pdfCitation Count: 56
-
RESTRICTEDTitle: Spectrum of impulse control behaviours in Parkinson’s disease: pathophysiology and managementJournal Name: Journal of Neurology, Neurosurgery & PsychiatryPublisher: BMJVol: 91Issue #: 7Start Page: 703End Page: 711Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1136/jnnp-2019-322453Best OA location URL: https://jnnp.bmj.com/content/jnnp/91/7/703.full.pdfCitation Count: 33
-
RESTRICTEDTitle: The Choice Between Advanced Therapies for Parkinson’s Disease Patients: Why, What, and When?Journal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 10Issue #: s1Start Page: S65End Page: S73Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202104Best OA location URL: https://europepmc.org/articles/pmc7592668?pdf=renderCitation Count: 38
- Simple system – substantial share: The use of Dictyostelium in cell biology and molecular medicine2013RESTRICTEDTitle: Simple system – substantial share: The use of Dictyostelium in cell biology and molecular medicineJournal Name: European Journal of Cell BiologyPublisher: Elsevier BVVol: 92Issue #: 2Start Page: 45End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.ejcb.2012.10.003Best OA location URL: https://pure.rug.nl/ws/files/141909462/1_s2.0_S0171933512001616_main.pdfCitation Count: 84
-
RESTRICTEDTitle: Neurodegenerative Disease Risk in Carriers of Autosomal Recessive DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.679927Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.679927/pdfCitation Count: 7
-
RESTRICTEDTitle: Effect of Antidepressants on Psychotic Symptoms in Parkinson Disease: A Review of Case Reports and Case SeriesJournal Name: Clinical NeuropharmacologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 43Issue #: 3Start Page: 61End Page: 65Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/wnf.0000000000000384Citation Count: 7
-
RESTRICTEDTitle: Extracellular Vesicles as Biomarkers and Therapeutic Tools: From Pre-Clinical to Clinical ApplicationsJournal Name: BiologyPublisher: MDPI AGVol: 10Issue #: 5Start Page: 359End Page: 359Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biology10050359Best OA location URL: https://www.mdpi.com/2079-7737/10/5/359/pdf?version=1619157483Citation Count: 84
-
RESTRICTEDTitle: Domotics, Smart Homes, and Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: s1Start Page: S55End Page: S63Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202398Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202398?id=journal-of-parkinsons-disease%2Fjpd202398Citation Count: 8
-
RESTRICTEDTitle: Current Concepts in the Treatment of Multiple System AtrophyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 6End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12145Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12145Citation Count: 24
-
RESTRICTEDTitle: Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 34Issue #: 1Start Page: 35End Page: 61Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2012.07.018Citation Count: 68
-
RESTRICTEDTitle: Targeting the Iron-Response Elements of the mRNAs for the Alzheimer’s Amyloid Precursor Protein and Ferritin to Treat Acute Lead and Manganese NeurotoxicityJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 20Issue #: 4Start Page: 994End Page: 994Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms20040994Best OA location URL: https://www.mdpi.com/1422-0067/20/4/994/pdf?version=1551081390Citation Count: 19
-
RESTRICTEDTitle: Mitochondria, lysosomes, and dysfunction: their meaning in neurodegenerationJournal Name: Journal of NeurochemistryPublisher: WileyVol: 147Issue #: 3Start Page: 291End Page: 309Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.14471Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.14471Citation Count: 88
-
RESTRICTEDTitle: Unconventional neurotrophic factors CDNF and MANF: Structure, physiological functions and therapeutic potentialJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 97Issue #:Start Page: 90End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2016.07.009Citation Count: 149
-
RESTRICTEDTitle: Serotonin transporter in Parkinson's disease: A meta‐analysis of positron emission tomography studiesJournal Name: Annals of NeurologyPublisher: WileyVol: 81Issue #: 2Start Page: 171End Page: 180Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/ana.24859Best OA location URL: https://kclpure.kcl.ac.uk/portal/files/62952075/Serontin_Transporter_in_Parkinson_s_disease_SERT_Accepted_GREEN_AAM.pdfCitation Count: 79
-
RESTRICTEDTitle: Fishing for Drug Targets: A Focus on Diazirine Photoaffinity Probe SynthesisJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 61Issue #: 16Start Page: 6945End Page: 6963Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1021/acs.jmedchem.7b01561Citation Count: 116
-
RESTRICTEDTitle: Multicellular hypothesis for the pathogenesis of Alzheimer's diseaseJournal Name: The FASEB JournalPublisher: WileyVol: 31Issue #: 5Start Page: 1792End Page: 1795Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1096/fj.201601221rCitation Count: 19
-
RESTRICTEDTitle: Understanding the Links Between Cardiovascular Disease and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 1Start Page: 55End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27836Best OA location URL: https://europepmc.org/articles/pmc6981000?pdf=renderCitation Count: 83
-
RESTRICTEDTitle: Magnetic resonance imaging as a potential biomarker for Parkinson's diseaseJournal Name: Translational ResearchPublisher: Elsevier BVVol: 175Issue #:Start Page: 4End Page: 16Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.trsl.2015.12.006Citation Count: 23
-
OPENTitle: Transcription Factor-Induced Lineage Selection of Stem-Cell-Derived Neural Progenitor CellsJournal Name: Cell Stem CellPublisher: Elsevier BVVol: 8Issue #: 6Start Page: 663End Page: 675Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.stem.2011.04.001Best OA location URL: http://www.cell.com/article/S1934590911001664/pdfCitation Count: 86
-
RESTRICTEDTitle: Parkinson’s Disease and the COVID-19 PandemicJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 2Start Page: 431End Page: 444Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202320Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202320?id=journal-of-parkinsons-disease%2Fjpd202320Citation Count: 73
-
RESTRICTEDTitle: Regulation of the Neurodegenerative Process Associated to Parkinson’s Disease by CD4+ T-cellsJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 10Issue #: 4Start Page: 561End Page: 575Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s11481-015-9618-9Citation Count: 52
-
RESTRICTEDTitle: Animal models of l‐dopa‐induced dyskinesia in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 889End Page: 899Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27337Citation Count: 71
- The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological Disorders2020RESTRICTEDTitle: The Coronavirus Disease 2019 Crisis as Catalyst for Telemedicine for Chronic Neurological DisordersJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 8Start Page: 927End Page: 927Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.1452Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/226023/226023.pdfCitation Count: 183
-
RESTRICTEDTitle: Identification of Risk Loci for Parkinson Disease in Asians and Comparison of Risk Between Asians and EuropeansJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 77Issue #: 6Start Page: 746End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.0428Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2764340/jamaneurology_foo_2020_oi_200012.pdfCitation Count: 153
-
RESTRICTEDTitle: Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources PanelJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 1Start Page: 102End Page: 102Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2020.3536Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7573798Citation Count: 150
-
RESTRICTEDTitle: Emerging Neuroimaging Biomarkers Across Disease Stage in Parkinson DiseaseJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 10Start Page: 1262End Page: 1262Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1312Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017381Citation Count: 75
-
RESTRICTEDTitle: Burden of Neurological Disorders Across the US From 1990-2017Journal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 2Start Page: 165End Page: 165Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1001/jamaneurol.2020.4152Best OA location URL: https://jamanetwork.com/journals/jamaneurology/articlepdf/2772579/jamaneurology_feigin_2020_oi_200081_1612851425.16285.pdfCitation Count: 314
-
RESTRICTEDTitle: Fovea and foveation in Parkinson's disease.Journal Name: Behavioral NeurosciencePublisher: American Psychological Association (APA)Vol: 127Issue #: 2Start Page: 139End Page: 150Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1037/a0031225Citation Count: 22
-
RESTRICTEDTitle: Post-stroke Movement Disorders: The Clinical, Neuroanatomic, and Demographic Portrait of 284 Published CasesJournal Name: Journal of Stroke and Cerebrovascular DiseasesPublisher: Elsevier BVVol: 27Issue #: 9Start Page: 2388End Page: 2397Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jstrokecerebrovasdis.2018.04.028Best OA location URL: https://zenodo.org/records/3873438/files/Proof_from_JSCVD-D-18-00257R1.pdfCitation Count: 65
-
RESTRICTEDTitle: Meta-analysis of amantadine efficacy for improving preclinical research reliabilityJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 10Start Page: 1555End Page: 1557Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.27486Citation Count: 7
-
RESTRICTEDTitle: Low Vitamin B12 and Parkinson DiseaseJournal Name: Mayo Clinic ProceedingsPublisher: Elsevier BVVol: 94Issue #: 5Start Page: 757End Page: 762Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.mayocp.2019.01.039Best OA location URL: http://www.mayoclinicproceedings.org/article/S0025619619301776/pdfCitation Count: 18